105 related articles for article (PubMed ID: 31558923)
1. Atypical cervical cytomorphologic predictors: a descriptive study of pre-cervical cancer patients of low education in Kenya.
Muitta E; Were T; Nyamache AK; Muhoho N
Pan Afr Med J; 2019; 33():124. PubMed ID: 31558923
[TBL] [Abstract][Full Text] [Related]
2. Reproductive and Lifestyle Characteristics of Kenyan Women Presenting With Precancerous Cervical Lesions: A Hospital-Based Case-Control Study.
Muitta E; Were T; Kebira AN
East Afr Health Res J; 2019; 3(2):115-124. PubMed ID: 34308204
[TBL] [Abstract][Full Text] [Related]
3. Difference Between Cryotherapy and Follow Up Low Grade Squamous Lesion of Cervix Uteri.
Jahic M; Jahic E; Mulavdic M; Hadzimehmedovic A
Med Arch; 2017 Aug; 71(4):280-283. PubMed ID: 28974850
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection.
Temmerman M; Tyndall MW; Kidula N; Claeys P; Muchiri L; Quint W
Int J Gynaecol Obstet; 1999 May; 65(2):171-81. PubMed ID: 10405062
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of high risk human papillomavirus infection with different cervical cytological features among women undergoing health examination at the National Cancer Institute, Thailand.
Laowahutanont P; Karalak A; Wongsena M; Loonprom K; Pukcharoen P; Jamsri P; Sangrajrang S
Asian Pac J Cancer Prev; 2014; 15(14):5879-82. PubMed ID: 25081717
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of clinical features of cervical precancerous lesions in postmenopausal women].
Liu YY; Guo RX; Li BJ; Wu Y; Bai J; Li LX; Wang CF
Zhonghua Fu Chan Ke Za Zhi; 2021 Feb; 56(2):114-120. PubMed ID: 33631883
[No Abstract] [Full Text] [Related]
8. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
9. [Precancerous lesions of the cervix and their treatment].
Sobel G
Magy Onkol; 2022 Dec; 66(4):280-287. PubMed ID: 36602247
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic human papilloma virus and cervical pre-cancerous lesions in brothel-based sex workers in India.
Sarkar K; Bhattacharya S; Bhattacharyya S; Chatterjee S; Mallick AH; Chakraborti S; Chatterjee D; Bal B
J Infect Public Health; 2008; 1(2):121-8. PubMed ID: 20701853
[TBL] [Abstract][Full Text] [Related]
11. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Colposcopic Biopsy Results of Patients Who have Cytomorphological Normal but HPV 16-18 or Other High-Risk HPV Subtypes Positive.
Aydoğmuş H; Aydoğmuş S
Asian Pac J Cancer Prev; 2019 Feb; 20(2):417-420. PubMed ID: 30803201
[TBL] [Abstract][Full Text] [Related]
13. Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy.
Chung MH; McKenzie KP; De Vuyst H; Richardson BA; Rana F; Pamnani R; Njoroge JW; Nyongesa-Malava E; Sakr SR; John-Stewart GC; Mugo NR
AIDS; 2013 Nov; 27(18):2909-19. PubMed ID: 23842133
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.
Mu-Mu-Shwe ; Harano T; Okada S; Aye-Aye-Win ; Khin-Saw-Aye ; Hlaing-Myat-Thu ; Mo-Mo-Win ; Khin-Khin-Oo ; Myo-Khin
Acta Med Okayama; 2014; 68(2):79-87. PubMed ID: 24743783
[TBL] [Abstract][Full Text] [Related]
15. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
Melinte-Popescu A; Costăchescu G
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
[TBL] [Abstract][Full Text] [Related]
16. Risk of high-grade lesions after atypical glandular cells in cervical screening: a population-based cohort study.
Norman I; Hjerpe A; Dillner J
BMJ Open; 2017 Dec; 7(12):e017070. PubMed ID: 29247086
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.
Uberti-Foppa C; Origoni M; Maillard M; Ferrari D; Ciuffreda D; Mastrorilli E; Lazzarin A; Lillo F
J Med Virol; 1998 Oct; 56(2):133-7. PubMed ID: 9746069
[TBL] [Abstract][Full Text] [Related]
18. Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia.
Ali KE; Mohammed IA; Difabachew MN; Demeke DS; Haile T; Ten Hove RJ; Kumssa TH; Woldu ZL; Haile EL; Tullu KD
BMC Cancer; 2019 Aug; 19(1):768. PubMed ID: 31382907
[TBL] [Abstract][Full Text] [Related]
19. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
